Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Oakley Capital acquires Horizons Optical
Oakley Capital, a pan-European middle-market private equity investor, has announced that Oakley Capital Origin Fund I has acquired a majority stake in Horizons Optical, a provider of medical software used to manufacture premium ophthalmic lenses. Get the week's top...
Goldman Sachs Asset Management raises over $700m for new fund
Goldman Sachs Asset Management said on Thursday it had raised over $700 million for a new fund that will work with external managers to identify investment opportunities in both public and private markets. The fund, Union Bridge Partners I, will work together with...
KKR mulls $1bn EuroKids school chain sale
KKR & Co is considering a sale of its controlling stake in Indian pre-school and early-learning provider EuroKids International for around $1bn, as well as other options for the business. The report cites unnamed sources as confirming that the US private equity...